Immunization against varicella and zoster;Vaccination contre la varicelle et contre le zona

Bulletin de l'Academie Nationale de Medecine

Volumn 191, Issue 6, 2007, Pages 1051-1067

  Floret, Daniel ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

Chickenpox vaccine; Herpes zoster vaccine

Indexed keywords

CHICKENPOX VACCINE; VARICELLA ZOSTER VACCINE;

AGE; ARTICLE; CHICKENPOX; CHILD; COMPARATIVE STUDY; FRANCE; HERPES ZOSTER; HUMAN; INCIDENCE; INFANT; PRESCHOOL CHILD; PREVENTIVE HEALTH SERVICE;

AGE FACTORS; CHICKENPOX; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; FRANCE; HERPES ZOSTER; HERPES ZOSTER VACCINE; HUMANS; IMMUNIZATION PROGRAMS; INCIDENCE; INFANT;

EID: 44449154313     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)32979-6     Document Type: Article

References (52)

1. BONMARIN I., NDIAYE E., SERINGE E, LÉVY-BRUHL D. -Épidémiologie de la varicelle en France. BEH, 2005, 08, 30-31.
2. http://rhone.b3e.jussieu.fr/senti/docs/bilan/2005/BilanRS2005-20060704. pdf
3. [3] WEIBEL R.E., NEFF B.J., KUTER B.J., GUESS HA., ROTHENBERGER CA., FITZGERALD AJ. et al. - Live attenuated varicella virus vaccine : efficacy trial in healthy children. N. Engl. J. Med., 1984, 310, 1409-1415. (Pubitemid 14101295)
4. KRAUSE PR., KLINMAN DM. -Efficacy, immunogenicity, safety and use of live attenuated chickenpox vaccine. J. Pediatr., 1995, 127, 518-525
5. ARVIN A.M. -Cell-mediated immunity to varicella-zoster virus. J. Infect Dis., 1992, 166, Suppl, S35-S41.
6. [6] MEURICE F., DE BOUVER JL., VANDERVOORDE D., WOODS S., BOGAERTS H. -Immunogenicity and safety of a live attenuated varicella vaccine (Oka/SB Bio) in healthy children. J. Infect. Dis., 1996, 774(suppl), S324-9. (Pubitemid 26357216)
7. [7] RAMKISSOON A., COOVADIA HM., JUGNUNDAN P., JUGNUNDAN P., HAFFEJEE IE., MEURICE F., et al. -Immunogenicity and safety of a live attenuated varicella vaccine in healthy children aged 9-24 months. S. Afr. Med. J, 1995, 85, 1295-1298 (Pubitemid 26018050)
8. [8] GERSHON AA., STEINBERG SP., LARUSSA P., FERRARA A., HAMMERSCLAG M., GELB L. - Immunization of healthy adults with live attenuated varicella vaccine. J. Infect. Dis., 1988, 158, 132-137 (Pubitemid 18189009)
9. [9] AMPOFO K., SAIMAN L., LARUSSA P., STEINBERG S., ANNUNZIATO P., GERSHON A. -Persistance of immunity to live attenuated varicella vaccine in healthy adults. Clin. Infect. Dis., 2002, 34, 774-779 (Pubitemid 34194847)
10. KUTER B.J., WEIBEL R.E., GUESS H.A.-Oka/Merck varicella vaccine in healthy children : final report of a 2-year efficacy study an 7-year follow-up studies. Vaccine, 1991, 9, 643-647
11. ROSS A.H. -Modification of chicken pox in family contacts by administration of gamma globulin. N. Engl. J. Med., 1962, 267, 369-376
12. [12] VARIS T., VESIKARI T. -Efficacy of high-titer live attenuated varicella vaccine in healthy young children. J. Infect. Dis.,1996, 174(suppl), S330-4. (Pubitemid 26357217)
13. [13] SALZMAN M.B., GARCIA C. -Postexposure varicella vaccination in siblings of children with active varicella. Pediatr. Infect. Dis. J, 1998, 17, 256-257. (Pubitemid 28146073)
14. WATSON B., SEWARD J., YANG A., WITTE P., LUTZ J., CHAN C., et al. -Postexposure effectiveness of varicella vaccine. Pediatrics, 2000, 105, 84-88.
15. [15] ARBETER A.M., STARR S.E., PLOTKIN S.A. -Varicella vaccine studies in healthy children and adults. Pediatrics, 1986, 78 Suppl, 748-756. (Pubitemid 16007078)
16. SEWARD J.F., WATSON B.M., PETERSON C.L., MASCOLA L., PELOSI J.W., ZHANG J.X., et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. J.A.M.A., 2002, 287, 606-611.
17. GALIK K., BROWN C., LIN F., SEWARD J. -Hospitalization for varicella in the United States, 1988 to 1999. Pediatr. Infect. Dis. J., 2002, 21, 931-934
18. [18] NGUYEN H.Q., JUMAAN A.O., SEWARD J.F. -Decline in mortality due to varicella after implementation of varicella vaccination in the United States. N. Engl. J. Med., 2005, 352, 450-458 (Pubitemid 40175971)
19. GERSHON A.A., STEINBERG S.P. -Live attenuated varicella vaccine : protection of healthy adults compared with leukemic children. National Institute of Allergy and infectious Disease Varicella Vaccine Collaborative Group. J. Infect. Dis., 1990, 161, 661-666
20. [20] SHIELDS K.E., GALIL K., SEWARD J., SHARRAR R.G., CORDERO J.F., SLATER E. -Varicella vaccine exposure during pregnancy : data from the first 5 years of the pregnancy registry. Obstet. Gynecol., 2001, 98, 14-19. (Pubitemid 32622757)
21. LEVRAT V., FLORET D., et le Groupe Francophone d'Urgence et de Réanimation Pédiatrique. - Caractéristiques cliniques des varicelles hospitalisées en réanimation pédiatrique de 1998 à 2001 en France. B.E.H., 2003, 09, 51-52
22. Avis du Conseil Supérieur d'Hygiène Publique de France (section des maladies transmissibles) relatif à la vaccination contre la varicelle : séance du 19 mars 2004. BEH, 2004, 28-29 : 127-129
23. [23] HAAS R.J., BELOHRADSKY B., DICKERHOFF R.R., ECHINGER K., EIFE R., HOLTMANN H., et al. - Active immunization against vermicelli of children with acute leukemia or other malignancies on maintenance chemotherapy. Postgrad. Med. J. 1985,61 (supp), 97-102. (Pubitemid 16050937)
24. [24] HEATH R.B., MALPAS J.S. -Experience with the live Oka-strain vaccine in children with solid tumors. Arch. Dis. Child, 1987, 62, 569-572 (Pubitemid 17086190)
25. [25] ZAMORA I., SIMON J.M, DA SILVA M.E., PIQUERAS A.I. -Attenuated varicella virus vaccine in children with renal transplants. Pediatr. Nephrol, 1994, 8, 190-192 (Pubitemid 24092256)
26. [26] GAGNADOUX M.F., TETE M.J., GUEST G., ROUZIOUX C., BROYER M. -Prévention de la varicelle chez les transplantés rénaux. J. Pediatr. Puériculture, 1998, 11, 226-229 (Pubitemid 128791098)
27. [27] DONATI M., ZUCKERMAN M., DHAWAN A., HADZIC N., HEATON N., NORTH-LEWIS P., et al. - Response to varicella immunization in pediatric liver transplants recipients. Transplantation, 2000, 70, 1401-1404 (Pubitemid 30840108)
28. [28] SAUERBREI A., PRAGER J., HENGST U., ZINTL F., WUTZLER P. -Varicella vaccination in children after bone marrow transplantation. Bone Marrow Transplantation, 1997, 20, 381-383 (Pubitemid 27390411)
29. [29] ALPAY H., YILDIZ N., ONAR A., TERNIZER H., OZCAY S. -Varicella vaccination in children with steroid-sensitive nephrotic syndrome. Pediatr. Nephrol, 2002, 17, 181-183 (Pubitemid 36076032)
30. CDC -Advisory Committee on Immunization Practices. June 29-30 2006. Atlanta, Georgia. http ://www.cdc.gov/nip/publications/acip-list-sup/acip-sup- varicella.htm
31. VAZQUEZ M., LARUSSA P.S., GERHSON A.A., NOCCOLAI L.M., MUEHLENBEIN C.E., STEINBERG S.P., et al -Effectiveness over time of varicella vaccine. J.A.M.A., 2004, 291, 851-855
32. [32] OZAKI T., NISSHIMURA N., KAJITA Y. -Experience with live attenuated varicella vaccine (Oka strain) in healthy Japanese subjects ; 10-year survey at pediatric clinic. Vaccine, 2000, 18, 2375-2380 (Pubitemid 30156808)
33. [33] TAKAYAMA N., MINAMITANI M., TAKAYAMA M. -High incidence of breakthrough varicelle observed in healthy children immunized with live attenuated varicella vaccine (Oka strain). Acta. Paediatr. Jpn., 1997, 39, 663-668 (Pubitemid 28057160)
34. [34] CHAVES S.C., GARGIULLO P., ZHANG J.X., CIVEN R., GURIS D., MASCOLA L., et al. -Loss of vaccine-induced immunity to varicella over time. N. Engl. J. Med., 2007, 356, 1121-1129 (Pubitemid 46425596)
35. [35] NGAI A., STAEHLE B.O., KUTER B.J., CYANOVICH N.M., CHO J., MATTHEWS H. et al. -Safety and immunogenicity of one vs. two injections of Oka/Merck varicella vaccine in healthy children. Pediatr. Infect. Dis. J., 1996, 15, 49-54. (Pubitemid 26029243)
36. WATSON B., ROTHSTEIN E., BERNSTEIN H., ARBETER A., ARVIN A., CHARTRAN S., et al-Safety and cellular and humoral response of a booster dose of varicella vaccine 6 years after primary immunization. J. Infect. Dis., 1995, 172, 217-219
37. [37] KUTER B., MATTHEWS H., SHINEFIELD H., BLACK S., DENNEHY P., WATSON B., et al.-Ten year follow-up of healthy children who received one or two injections of varicella vaccine. Pediatr. Infect. Dis. J, 2004, 25, 132-137 (Pubitemid 38222785)
38. BLACK S., SHINEFIELD H., RAY P., LEWIS E., HANSEN J., SCHWALBE J., et al. -Postmarketing evaluation of the safety and effectiveness of varicella vaccine. Pediatr. Infect. Dis. J., 1999, 18, 1041-1046
39. SHARRAR R.G., LARUSSA P., GALEA S.A., STEINBERG S.P., SWEET A.R., KEATLEY R.M., et al. The postmarketing safety profile of varicella vaccine. Vaccine, 2000, 19, 916-923
40. [40] SCHEIFELE D.W., HALPERIN S.A., DIAZ-MITOMA F. -Three-year follow-up of protection rates in children given varicella vaccine. Can. J. Infect. Dis., 2002, 13, 382-386 (Pubitemid 36188386)
41. [41] THOMAS S.L., WHEELER J.G., HALL A.J. -Contacts with varicella or with children and protection against herpes zoster in adults : a case-control study. Lancet, 2002, 360, 678-682 (Pubitemid 35232336)
42. [42] BRISSON M., GAY N.J., EDMUNDS W.J., ANDREWS N.J. -Exposure to varicella boosts immunity to herpes -zoster : implications for mass vaccination against chickenpox. Vaccine, 2002, 3207, 1-8. (Pubitemid 34615588)
43. GOLDMAN G.S. -Incidence of herpes zoster among children and adolescents in a community with moderate vaccination coverage. Vaccine, 2002, 21, 4243-4249
44. [44] YIH W.K., BROOKS D.R., LETT S.M., JUMAAN A.O., ZHANG Z., CLEMENTS K.M., et al. -The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioural Risk Factor Surveillance System (BRFSS) during a period of increasing varicella coverage 1998, 2003. BMC Public Health, 2005, 5, 6. (Pubitemid 41096318)
45. [45] HUSE D.M., MEISSNER H.C, LACEY M.J., OSTER G. -Childhood vaccination against chicken pox : an analysis of benefits and costs. J Pediatr., 1994, 124, 869-874 (Pubitemid 24184010)
46. [46] BEUTELS P., CLARA R., TORMANS G., VAN DOORSLAER E., VAN DAMME P. -Costs and benefits of routine varicella vaccination in German children. J. Infect. Dis., 1996, 775(Suppl), S335-41. (Pubitemid 26357218)
47. [47] BANZ K., WAGENPFEIL S., NEISS A. GOERTZ A., STAGINNUS U., VOLLMAR J., et al -The cost-effectiveness of routine childhood varicella vaccination in Germany. Vaccine, 2003, 21, 1256-1267 (Pubitemid 36139958)
48. [48] BRISSON M., EDMUNDS W.J., GAY NJ. -Varicella vaccination : impact of vaccine efficacy on the epidemiology of VZV. J Med Virol, 2003, 70 Suppl 1, S31-7. (Pubitemid 36368842)
49. [49] COUDEVILLE L., BRUNOT A., SZUCS T.D. -The economic value of chilhood varicella vaccination in France and in Germany. Value Health, 2005, 8, 209-212 (Pubitemid 41023480)
50. [50] OXYMAN M.N., LEVIN M., JOHNSON G.R., SCHMADER K.E., STRAUSS S.E., GELB L.D., et al. - A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N. Engl. J. Med., 2005, 352, 2271-2284 (Pubitemid 40740551)
51. Avis du Conseil supérieur d'Hygière publique de France (section des maladies transmissibles) relatif au vaccin contre le zona. Séances du 22 septembre et du 05 décembre 2006. http ://www. sante.gouv.fr/htm/pointsur/vaccins/index.htm
52. PINOT DE MOIRA A., NARBONE A. -Varicella Zoster virus vaccination policies and surveillance strategies in Europe. Eurosurveillance, 2005, 10, 43-45